Alterations in the expression of daunorubicin phase-I metabolising enzymes in different carcinoma cell lines.
Koch
L
L
Department of Pharmacology and Toxicology, University of Marburg, Germany.
Maser
E
E
Soldan
M
M
D000429:Alcohol Oxidoreductases / Q000235:genetics; D000449:Aldehyde Reductase / Q000235:genetics; D000074408:Aldo-Keto Reductases; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D003630:Daunorubicin / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000201:enzymology*; D010088:Oxidoreductases / Q000235:genetics; D010190:Pancreatic Neoplasms; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D010088:Oxidoreductases; D000429:Alcohol Oxidoreductases; D000074408:Aldo-Keto Reductases; C019642:alcohol dehydrogenase (NADP+); D000449:Aldehyde Reductase; C048338:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase; D003630:Daunorubicin